Chicago Cornea Consultants (United States) is a company in Chicago, United States.
“Keratoconus is a non-inflammatory eye condition in which the typically dome-shaped cornea progressively thins and weakens, causing the development of a cone-like bulge and optical irregularity of the cornea. This progressive change in the shape of the corneal causes visual disturbance.”
“Cross-linking is a minimally invasive, FDA approved, outpatient procedure that combines the use of prescription eye drops, Photrexa® Viscous(riboflavin5’-phosphate in 20% dextran ophthalmic solution), Photrexa® (riboflavin 5’-phosphate ophthalmic solution), and ultra-violet A (UVA) light from the KXL® system for the treatment of progressive keratoconus.”
“After numbing drops are applied, the epithelium (the thin layer on the surface of the cornea) is gently removed. Next Photrexa Viscous eye drops will be applied to the cornea for at least 30 minutes. The cornea is then exposed to UV light for 30 minutes while additional Photrexa Viscous drops are applied.”
“UVA is one of the three types of invisible light rays given off by the sun (together with ultra-violet B and ultra-violet C) and is the weakest of the three.”
“The EVO ICL is a type of implantable contact lens that is surgically placed in the eye to correct nearsightedness and astigmatism. It is made of a biocompatible material called Collamer, which is engineered to be well-tolerated by the eye.”
“The EVO ICL is implanted through a small incision in the eye. It is placed behind the iris and in front of the natural crystalline lens. The procedure is performed using local anesthesia and takes about 15 minutes per eye.”
“The EVO ICL is intended for patients with myopia (nearsightedness) and astigmatism who are not good candidates for LASIK or other types of refractive surgery. It is also suitable for patients who have thin corneas or dry eyes.”
“The EVO ICL offers several benefits over other types of refractive surgery. It is reversible, which means that it can be removed if necessary. It also provides excellent visual quality, UV protection, less risk of post-operative dry eye, and patients typically experience little to no glare or halos at night.”
“SMILE (Small Incision Lenticule Extraction) is a type of laser vision correction surgery that uses the VisuMax® femtosecond laser to remove a small piece of tissue from the cornea, correcting refractive errors such as myopia (nearsightedness) and astigmatism. The procedure is minimally invasive and does not require the creation of a corneal flap, as is the case with LASIK.”
“During the ZEISS ReLEx SMILE procedure, the VisuMax® femtosecond laser creates a small incision in the cornea. A lenticule, or small piece of tissue, is then removed through this incision. This process alters the shape of the cornea, correcting the refractive error. The procedure is typically performed on both eyes and takes approximately 15-30 minutes.”
“The SMILE Procedure has several advantages over other laser vision correction surgeries. One of the main benefits is that it is a minimally invasive procedure that does not require the creation of a corneal flap. This means that there is less risk of postoperative dry eye and less discomfort during the healing process.”
Download this profile and inspect its supporting evidence.